Follow the Addus HomeCare Corp stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Addus HomeCare Corp has logged 277 insider filings. Market capitalisation: €2bn. The latest transaction was reported on 23 June 2026 (Cession). Among the most active insiders: ALLISON R DIRK. All data is free.
Analysts rate Addus HomeCare Corp Buy (bullish), based on 13 analysts. Average price target: US$132.69.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 277 declarations
Addus HomeCare Corp. (ticker: ADUS) is a U.S.-based home care services company listed on the NASDAQ in the United States. For French-speaking investors, it is best viewed as a specialized healthcare-services provider operating in a segment supported by long-term demographic and policy trends: an aging population, patient preference for care delivered at home, and the ongoing pressure on public and private payers to reduce the cost of post-acute and chronic care. Addus operates three core business lines: personal care, hospice, and home health. Its services are delivered primarily in patients’ homes under arrangements with federal, state and local government agencies, managed care organizations, commercial insurers, and private individuals. A meaningful share of its consumer base is “dual eligible,” meaning beneficiaries qualify for both Medicare and Medicaid. The company traces its origins to 1979, when it began providing home care services. Addus was incorporated in Delaware in July 2006 and completed its initial public offering in October 2009. Over time, the company has broadened its footprint through a mix of organic growth and acquisitions. Its corporate office is in Frisco, Texas, and it also maintains a support center in Downers Grove, Illinois. As of year-end 2024, Addus was serving customers across 23 states through approximately 258 offices, giving it a diversified but still regionally focused operating base. From a competitive standpoint, Addus differentiates itself through local density, payer relationships, and the gradual expansion of clinical capabilities. Management’s strategy has been to deepen presence in existing states while adding clinical care services to complement personal care. In selected markets, the company now offers all three levels of care, which can improve patient retention, referral relationships, and cross-selling opportunities. This model is particularly relevant in home-based care, where scale, reimbursement management, and local execution matter materially. In 2024, Addus reported net service revenue of $1.15 billion, with personal care representing the largest share of revenue, followed by hospice and home health. The company served approximately 105,000 discrete consumers during the year. Recent developments underscore the company’s acquisition-led growth strategy. On December 2, 2024, Addus completed the acquisition of Gentiva’s personal care business, a transaction that strengthened its market density, especially in Texas. In 2025, it continued to expand through the acquisition of Helping Hands Home Care Service. More recently, in early 2026, Addus reported strong full-year 2025 results and highlighted supportive state funding trends, including a significant rate increase in Texas effective September 1, 2025. Overall, ADUS stands out as a NASDAQ-listed U.S. home care platform with exposure to durable structural demand, recurring reimbursement relationships, and a proven acquisition strategy.